November 02, 2021
The Centers for Disease Control and Prevention’s (CDC) advisory panel voted 14–0 to recommend the use of the Pfizer-BioNTech COVID-19 vaccine for children between 5 and 11.
The recommendation is one of the final hurdles before the vaccine can be administered to children in this age group. CDC Director Rochelle Walensky is expected to issue a final decision shortly.
At the start of today’s meeting, Dr. Walensky thanked the Advisory Committee on Immunization Practices for its review of the risks and benefits of the vaccine, calling it a “monumental day” during the pandemic.
While severe COVID-19 outcomes are rare in children, there are still risks, Dr. Walensky said. She also highlighted the ways the pandemic has affected children’s social, mental, and behavioral health.
“The risk is too high and too devastating to our children, and far higher than for many other diseases for which we vaccinate children,” Dr. Walensky said.
Here’s what you need to know from Tuesday’s meeting:
Once the vaccine is authorized under emergency use, the nation’s COVID-19 vaccine providers can begin the rollout in this age group. The widespread rollout of the vaccine is expected to begin in earnest next week, the nation’s COVID-19 Response Team said.
HAP will continue to monitor the latest COVID-19 public health developments and provide updates to members and the general public. Today’s meeting materials are available for review online.
Tags: Public Health | COVID-19
Click on topic below for category-specific news articles.
Support a healthier Pennsylvania.